| 2007 |
IL-17RC binds both IL-17A and IL-17F with high affinity and functions as a receptor for both cytokines; a soluble form of IL-17RC blocks binding of both IL-17A and IL-17F and inhibits their signaling. |
Binding assays, soluble receptor antagonism experiments, signaling inhibition assays |
Journal of immunology |
High |
17911633
|
| 2010 |
IL-17RC does not preassociate with IL-17RA on the cell surface; instead, IL-17A induces formation of an IL-17RC/IL-17RA complex. This ligand-induced complex formation is not dependent on the intracellular SEFIR domain of IL-17RC, but the SEFIR domain is essential for IL-17A signal transduction. IL-17RC is absolutely required for signaling by IL-17A, IL-17F, and IL-17A/F heterodimers both in vitro and in vivo. |
Il-17rc-deficient (knockout) mice, cell surface co-association assays, in vitro signaling assays, EAE disease model |
Journal of immunology |
High |
20231694
|
| 2010 |
The IL-17RC cytoplasmic tail contains a SEFIR domain that is necessary but not sufficient for IL-17-dependent signaling; an additional sequence downstream of the SEFIR (extended SEFIR) is also required. IL-17RC inducibly associates with a specific glycosylated isoform of IL-17RA independently of its own cytoplasmic tail. IL-17RC directly interacts with the adaptor/E3 ubiquitin ligase Act1, and functional IL-17RC isoforms containing the extended SEFIR region interact specifically with a phosphorylated isoform of Act1. |
IL-17RC deletion mutant panel in IL-17RC−/− fibroblasts (functional reconstitution), Co-IP/pulldown for Act1 interaction, target gene expression assays (IL-6, lipocalin-2) |
Journal of immunology |
High |
20554964
|
| 2015 |
Complete autosomal-recessive IL-17RC deficiency abolishes cellular responses to IL-17A and IL-17F homo- and heterodimers but leaves IL-17E (IL-25) responses intact, establishing that IL-17RC is specifically required for IL-17A/F signaling and is essential for mucocutaneous immunity to Candida albicans. |
Primary cells from patients with homozygous nonsense alleles preventing IL-17RC surface expression; cytokine stimulation/response assays |
The Journal of experimental medicine |
High |
25918342
|
| 2020 |
Crystal structure of the extracellular domain of human IL-17RC in complex with IL-17F reveals a symmetrical 2:1 (receptor:cytokine) complex, in which two IL-17RC molecules bind one IL-17F homodimer. IL-17A and IL-17A/F also form 2:1 complexes with IL-17RC as shown by biophysical techniques, suggesting the possibility of IL-17RA-independent IL-17 signaling through IL-17RC. |
X-ray crystallography (crystal structure), biophysical binding assays (SPR/ITC) |
Immunity |
High |
32187518
|
| 2020 |
IL-17RC signaling in adipocytes is required for TGFβ1 expression, which promotes sympathetic innervation of thermogenic adipose tissue. Adipose-tissue-specific ablation of IL-17RC reduces TGFβ1 in adipocytes, impairs local sympathetic innervation, and causes obesity and defective thermogenesis; innervation is fully rescued by restoring TGFβ1 expression. γδ T cells drive this process upstream of IL-17RC. |
Adipose-tissue-specific IL-17RC knockout mice, TGFβ1 rescue experiments, sympathetic innervation quantification, metabolic phenotyping |
Nature |
High |
32076265
|
| 2008 |
Both IL-17RA and IL-17RC are required for IL-17A-induced IL-6, IL-8, and CCL-20 secretion in rheumatoid synoviocytes; siRNA knockdown of either receptor alone nearly abrogates IL-17A-mediated IL-6 secretion, and combined knockdown is needed to suppress IL-17A+TNF-α-induced responses. |
siRNA knockdown of IL-17RA and IL-17RC individually and in combination; ELISA for cytokine secretion; microarray gene expression |
Journal of immunology |
Medium |
18097068
|
| 2007 |
Inhibition of either IL-17RA or IL-17RC expression via siRNA leads to near-complete abrogation of IL-17A-mediated c-Jun and p65 NF-κB activation and IL-8 secretion in gastric adenocarcinoma cells, indicating both receptors are required for IL-17A signaling. |
siRNA knockdown, Western blot, transcription factor binding assays, ELISA |
Cytokine |
Medium |
17644350
|
| 2017 |
Follistatin-like protein 1 (FSTL-1) is necessary for Il17rc gene transcription and IL-17RC surface protein expression in bone marrow stromal cells; loss of FSTL-1 reduces IL-17RC levels and abolishes IL-17-dependent IL-6 and G-CSF production, identifying FSTL-1 as an upstream regulator of IL-17RC expression. |
In vitro FSTL-1 suppression (bone marrow stromal cells), microarray, surface protein expression assays, cytokine production assays |
Immunology and cell biology |
Medium |
28377613
|
| 2017 |
IL-17RC knockdown in B16 melanoma and 4T1 carcinoma cells diminishes baseline A20 (ubiquitin-editing enzyme) levels and causes aberrant differential upregulation of JNK1 or JNK2, respectively, leading to reciprocal changes in tumor-specific proliferation. Reconstitution with full-length A20 (but not a truncation mutant) reverses aberrant JNK activity and restores normal proliferation, establishing an IL-17RC–A20–JNK axis in tumor cells. |
shRNA knockdown of IL-17RC, A20 reconstitution with full-length and truncation mutants, Western blot for JNK isoforms, in vitro and in vivo tumor proliferation assays |
Oncotarget |
Medium |
28562353
|
| 2019 |
A missense mutation (rs199772854A) in IL17RC overexpresses the protein and significantly increases expression of TRAF6 and NF-κB in osteoblasts, promoting osteogenic differentiation, suggesting IL-17RC signals through the IL-17/TRAF6/NF-κB axis to drive ectopic osteogenesis. |
Overexpression of mutant and WT IL17RC in 3T3-E1 osteoblasts, RT-qPCR, Western blot for osteogenic markers and NF-κB pathway components |
International journal of molecular medicine |
Low |
30864693
|
| 2022 |
Recombinant IL-17A induces expression of IL-17RC in gastric cancer cells (AGS), leading to NF-κB activation and increased NADPH oxidase 1 (NOX1) levels; inhibition of NOX1 attenuates IL-17A-mediated cancer cell growth, ROS generation, and cancer stem cell stemness, placing IL-17RC upstream of an NF-κB/NOX1 axis. |
Recombinant cytokine stimulation, pharmacological NOX1 inhibition, in vitro growth and sphere formation assays, IL-17A KO mice with H. pylori/MNU-induced GC model |
Gastric cancer |
Medium |
36125689
|
| 2023 |
A novel homozygous duplication variant in IL17RC (exon 13, causing frameshift and premature stop p.D457Afs*16) is loss-of-function; patient SV40-immortalized fibroblasts lack response to IL-17A, and this defect is restored by introducing wild-type IL17RC, confirming the receptor's essential role in IL-17A signal transduction. |
Flow cytometry, qPCR, RNA-sequencing, immunoblotting, IL17RC-knockout cell line complementation with WT IL17RC |
Journal of clinical immunology |
High |
38129603
|
| 2017 |
UVB irradiation downregulates IL-17RA and IL-17RC expression on human dermal fibroblasts through TGF-β1/Smad3 signaling, thereby inhibiting IL-17A/TNF-α-induced IL-6, IL-8, and CXCL-1 production. |
UVB irradiation of cultured fibroblasts, TGF-β1 treatment, Western blot, qPCR, ELISA, flow cytometry for receptor expression |
Frontiers in immunology |
Low |
28217129
|
| 2026 |
IL-17RC signaling in intestinal epithelial cells maintains intestinal barrier integrity and controls microbiota composition; loss of IL-17RC in intestinal epithelial cells alters the microbiota, enhances perivascular innervation and aortic inflammation, and augments atherosclerosis. Cell-autonomous IL-17RC signaling in sympathetic neurons is also required, as neuron-specific IL-17RC ablation protects mice from microbiota-driven atherosclerosis. |
Cell-type-specific IL-17RC knockout mice (intestinal epithelial and sympathetic neuron), microbiota analysis, chemical denervation, γδ T cell blockade, disease progression quantification |
bioRxivpreprint |
Medium |
41959117
|